| Study |
Reference |
|
Bànhidy (Primidone), 2011
|
Bànhidy Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:34-42
|
|
Battino, 2024
|
Battino Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 2024; 81:481-489 Tomson Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018; 17:530-538 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
|
|
Battino (Primidone), 1999
|
Battino Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res 1999; 36:53-60
|
|
Battino (Primidone), 1992
|
Battino Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85:204-7 Canger Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999; 40:1231-6
|
|
Burja (Primidone) (Controls unexposed, disease free), 2006
|
Burja The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study. Wien Klin Wochenschr 2006; 118 Suppl 2:12-6
|
|
Burja (Primidone) (Controls unexposed, sick), 2006
|
Burja The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study. Wien Klin Wochenschr 2006; 118 Suppl 2:12-6
|
|
Canger (Primidone), 1999
|
Canger Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999; 40:1231-6
|
|
Christensen (Primidone) (Epilepsy) (Controls exposed to LTG), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
|
|
Christensen (Primidone) (Epilepsy) (Controls unexposed, general population), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
|
|
Czeizel (Primidone), 1992
|
Bànhidy Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:34-42 Czeizel Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 1992; 8:122-7
|
|
Dean (Primidone), 2002
|
Dean Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002; 39:251-9
|
|
Kaaja (Primidone), 2003
|
Kaaja Major malformations in offspring of women with epilepsy. Neurology 2003; 60:575-9
|
|
Kaneko (Primidone), 1999
|
Battino Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85:204-7 Canger Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999; 40:1231-6 Kaneko Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999; 33:145-58 Kaneko Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia ; 29:459-67
|
|
Katz (Primidone), 2001
|
Katz Current Management of Epilepsy and Pregnancy: Fetal Outcome, Congenital Malformations, and Developmental Delay. Epilepsy Behav 2001; 2:119-123
|
|
Kini (Primidone) (Controls exposed to Lamotrigine, sick), 2006
|
Kini Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006; 91:F90-5
|
|
Kini (Primidone) (Controls unexposed, sick), 2006
|
Kini Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006; 91:F90-5
|
|
Koch (Primidone), 1996
|
Koch Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta Paediatr 1996; 85:739-46
|
|
Lowe (Primidone) (Controls unexposed, disease free), 1973
|
Lowe Congenital malformations among infants born to epileptic women. Lancet 1973; 1:9-10
|
|
Lowe (Primidone) (Controls unexposed, sick), 1973
|
Lowe Congenital malformations among infants born to epileptic women. Lancet 1973; 1:9-10
|
|
Samrén (Primidone), 1999
|
Samrén Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46:739-46
|
|
Steegers-Theunissen (Primidone), 1994
|
Steegers-Theunissen Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study. Epilepsy Res 1994; 18:261-9
|
|
Titze (Primidone) (Controls unexposed, disease free), 2008
|
Titze Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-22
|
|
Titze (Primidone) (Controls unexposed, sick), 2008
|
Titze Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-22
|
|
Vajda (Primidone) (Controls exposed to Lamotrigine, sick), 2019
|
Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8
|
|
Vajda (Primidone) (Controls unexposed, sick), 2019
|
Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8
|
